Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B

American Journal of Gastroenterology

Volumn 94, Issue 11, 1999, Pages 3304-3309

  Arase, Yasuji ^a   Ikeda, Kenji ^a   Murashima, Naoya ^a   Chayama, Kazuaki ^a   Tsubota, Akihito ^a   Koida, Isao ^a   Suzuki, Yoshiyuki ^a   Saitoh, Satoshi ^a   Kobayashi, Masahiro ^a   Kobayashi, Mizuho ^a   Kobayashi, Mariko ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; VIRUS REPLICATION;

ADULT; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; BIOPSY; CONFIDENCE INTERVALS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; NECROSIS; ODDS RATIO; PREDNISOLONE; PROPORTIONAL HAZARDS MODELS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0032757065     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00601-2     Document Type: Article

References (23)

1. Aikawa T., Sairenji H., Furuta S., et al. Seroconversion from hepatitis B e antigen to anti-HBe in acute hepatitis B virus infection. N Engl J Med. 298:1978;439.
2. Realdi G., Alberti A., Rugge M., et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology. 79:1980;195-199.
3. Hoofnagle J.H., Dusheiko G.M., Seeff L.B., et al. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med. 94:1981;744-748.
4. Lam K.C., Lai C.L., Trepo C., et al. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med. 304:1981;380-386.
5. Scullard G.H., Robinson W.A., Merigan T.C., et al. Effect of immunosuppressive therapy on hepatitis B viral infection in patients with chronic hepatitis. Gastroenterology. 77:1979;A40.
6. Muller R., Vido I., Schmidt F.W. Rapid withdrawal of immunosuppressive therapy in chronic active hepatitis B infection. Lancet. I:1981;1323-1324.
7. Weller I.V., Bassendine M.F., Murray A.K., et al. Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. Gut. 23:1982;650-655.
8. Nair P.V., Tong M.J., Stevenson D., et al. A pilot study on the effects of prednisolone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B. Hepatology. 6:1986;1319-1324.
9. Kumada H., Ikeda K., Yoshiba A., et al. Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. Jpn J Med. 26:1987;217-222.
10. Hoofnagle J.H., Davis G.L., Pappas S.C., et al. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double blind, placebo-controlled trial. Ann Intern Med. 104:1986;12-17.
11. Alberti A., Pontisso P., Fattovich G., et al. Changes in serum hepatitis B virus (HBV) DNA positivity in chronic infection. Results of a long-term follow-up study of 138 patients. J Infect Dis. 154:1986;562-569.
12. Knodell R.G., Ishak K.G., Black W.C., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
13. Schvarcz R., Glaumann H., Weiland O., et al. Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis. Liver. 11:1991;30-38.
14. Scheuer P.J. Classification of chronic viral hepatitis a need for reassessment . J Hepatol. 1991;372-374.
15. Desmet V.J., Gerber M., Hoofnagle J.H., et al. Classification of chronic hepatitis Diagnosis, grading and staging . Hepatology. 19:1994;1513-1520.
16. Harrington D.P., Fleming T.R. A class of rank test procedures for censored survival data. Biomediaica. 62:1983;553-566.
17. Cox D.R. Regression models and life tables. J R Stat Soc. 34:1972;248-275.
18. Dixon W.J., Brown M.B., Engleman L. BMDP Statistical software. 1985;University of California, Berkeley.
19. Bonino F., Rosina F., Rizzetto M., et al. Chronic hepatitis in HBsAg carriers with serum HBV DNA and anti HBe. Gastroenterology. 90:1986;1268-1273.
20. Fattovich G., Rugge M., Brollo L., et al. Clinical virologic and histologic outcome following seroconversion from HBe in chronic hepatitis Type B. Hepatology. 6:1986;167-172.
21. Fattovich G., Brollo L., Albert A., et al. Long-term follow up of anti HBe-positive chronic active hepatitis B. Hepatology. 8:1988;1651-1654.
22. Tsubota A., Kumada H., Chayama K., et al. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-α̇ therapy for chronic hepatitis C virus infection. J Hepatol. 27:1997;49-55.
23. Loriot M.-A., Marcellin P., Walker F., et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol. 27:1997;251-258.